Concepedia

Garry Pairaudeau

GP

Statistics

Publications

28

Citations

1.3K

H-Index

20

Active since

1987

Affiliations

AstraZeneca (United Kingdom)(Current)

Loughborough University

AstraZeneca (Sweden)

Newcastle University

AstraZeneca (Singapore)

Garry Pairaudeau is an author at AstraZeneca (United Kingdom) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

1987–2024

28

Publications

28

From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis

Brian Springthorpe, A. S. Bailey, Patrick Barton et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 235 citations · Full text

, , +12

Synthesis applications of cationic aza-Cope rearrangements. 26. Enantioselective total synthesis of (-)-strychnine

Steven D. Knight, Larry E. Overman, Garry Pairaudeau · Journal of the American Chemical Society · 1993 · 172 citations

, , +9

Asymmetric Total Syntheses of (-)- and (+)-Strychnine and the Wieland-Gumlich Aldehyde

Steven D. Knight, Larry E. Overman, Garry Pairaudeau · Journal of the American Chemical Society · 1995 · 140 citations

, , +5

Potent Reversible Inhibition of Myeloperoxidase by Aromatic Hydroxamates

Louisa V. Forbes, Tove Sjögren, Françoise Auchère et al. · Journal of Biological Chemistry · 2013 · 103 citations · Full text

, , +8

QSAR and the Rational Design of Long-Acting Dual D<sub>2</sub>-Receptor/β<sub>2</sub>-Adrenoceptor Agonists

Rupert P. Austin, Patrick Barton, Roger V. Bonnert et al. · Journal of Medicinal Chemistry · 2003 · 65 citations

, , +17

1–5 of 28